表紙
市場調査レポート

世界のタンパク質療法市場

Global Protein Therapeutics Market Outlook 2020

発行 RNCOS E-Services Pvt. Ltd. 商品コード 235810
出版日 ページ情報 英文 165 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
世界のタンパク質療法市場 Global Protein Therapeutics Market Outlook 2020
出版日: 2015年09月01日 ページ情報: 英文 165 Pages
概要

タンパク質療法は、癌から代謝性疾患まで幅広い病気に対する最も効果的な処置の一つとなっています。この市場は将来大きく成長する可能性があり、2020年末までに2,080億米ドルの規模に達すると予測されています。

当レポートでは、タンパク質療法の世界市場について分析し、全体的な市場構造や動向予測、主な治療法・治療薬の概要と市場動向の予測、最新の薬剤開発動向、市場の新たな傾向、主要企業のプロファイルなどを調査・推計して、その結果をお届けします。

第1章 アナリストの見解

第2章 分析手法

第3章 世界のタンパク療法市場

  • タンパク療法市場と医薬品市場
  • 現在・将来の市場の分析
    • 市場の分類
    • 市場力学
      • 成長促進要因
      • 抑制因子
      • 課題
      • 機会

第4章 産業の実績

  • モノクローナル抗体(mAbs)
    • 科学的考察
    • 現在・将来の市場の分析
    • 用途別分析
    • 主な市場地域
    • 主な企業と薬剤
    • 近年の発展
  • エリスロポエチン(EPO)
    • 科学的考察
    • 現在・将来の市場の分析
    • 用途別分析
    • 主な市場地域
    • 主な企業と薬剤
    • 近年の発展
  • インスリン
    • 科学的考察
    • 現在・将来の市場の分析
    • 用途別分析
    • 主な市場地域
    • 主な企業と薬剤
    • 近年の発展
  • インターフェロン(IFN)
    • 科学的考察
    • 現在・将来の市場の分析
    • 用途別分析
    • 主な市場地域
    • 主な企業と薬剤
    • 近年の発展
  • ヒト成長ホルモン(HGH)
    • 科学的考察
    • 現在・将来の市場の分析
    • 主な市場地域
    • 主な企業と薬剤
    • 近年の発展
  • 血液凝固因子
    • 科学的考察
    • 現在・将来の市場の分析
    • 因子別分析
    • 主な市場地域
    • 主な企業と薬剤
    • 近年の発展
  • 卵胞刺激ホルモン(FSH)
    • 科学的考察
    • 現在・将来の市場の分析
    • 主な企業と薬剤
    • 近年の発展
  • 顆粒球コロニー刺激因子(G-CSF)
    • 科学的考察
    • 現在・将来の市場の分析
    • 主な市場地域
    • 主な企業と薬剤
    • 近年の発展

第5章 治験の最終段階にある薬剤の分析

第6章 市場の新たな傾向

  • 本格化:新たな治療法を開発するための企業間の戦略的活動
  • 効果的な到達方法:治療薬の有効範囲の拡大
  • 多発性硬化症および癌の治療に多額の投資をする企業
  • 新たなバイオ医薬品、「バイオベター」の開発に注力

第7章 主要企業

  • Johnson & Johnson
  • Biogen Idec Inc.
  • Eli Lilly & Company
  • Sanofi-Aventis
  • Merck Serono S.A.
  • Roche Group
  • Amgen Inc.
  • Pfizer
  • Abbott Laboratories
  • Novo Nordisk

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Once a rarely used subset of medical treatments, protein therapies have now found application in a large number of medical conditions. Since the introduction of the first recombinant protein therapeutic, the human insulin, the protein therapeutics market has revolutionized tremendously. Due to its increased usage, the market holds huge potential for future growth and it is estimated that by the end of 2020, it may reach the mark of US$ 208 Billion. Furthermore, the launch of new products is also likely to propel the market growth.

According to our new research report, “Global Protein Therapeutics Market Outlook 2020”, a large number of existing and new market players are rigorously involved in developing monoclonal antibodies (mAbs). The mAbs segment accounts for the largest share in the current protein therapeutic products. The report, in this context, gives a comprehensive analysis of the current and future patterns of revenue generation with respect to mAbs and other segments, which includes insulin, EPO, interferon, G-CSF, human growth hormone , blood clotting factors and FSH.

The report takes into account all the important aspects of the global protein therapeutics market, and projects the market during the period 2013-2020. Some of the key aspects included in the report are the market share analysis of key players and the segmental analysis. The report also provides in depth analysis of various applications of the above mentioned protein therapeutics. The current as well as the future market prospects of the applications of major protein therapeutics is also provided in the report.

Through in-depth and careful analysis of the worldwide developments, we have observed that the US continues to hold a dominant position in the global protein therapeutics market, as the country provides a major proportion of the products' sales. However, our team of researchers has come up with an analysis that the future landscape looks promising, with respect to major contribution from emerging economies, which can be attributed to increasing awareness among people and an increased healthcare expenditure owing to the increase in the disposable income.

The report also covers an advanced phase drug analysis. This chapter lists all the protein therapeutics of the major players, which are in the third phase of the clinical trial. This analysis will help the client in understanding the potential market for the future. It also helps understand the major segments, indications and players in Protein Therapeutics that will continue to rule the market.

The report also states market forces that would govern the market, the drivers for the market, the challenges encountered by the market players, and the opportunities that the new and existing market players could grab, thereby resulting in the growth of the market. Moreover, the report provides a summary of the recent trends that may have an impact on the future industry performance.

The report provides insight about the lucrativeness of the industry through Porter's Five Forces Analysis. This analysis will help the industry players to understand the level of competition within an industry, and would assist in business strategy development.

At the end, the key players of the market have been enlisted. A brief business overview of every player has been provided along with its product portfolio. This is followed by the recent developments of the player that may impact the market in the future. Overall, the report will prove to be a complete source of knowledge, and analysis for clients and potential investors.

Table of Contents

1. Analyst View

2. Research Methodology

3. Global Protein Therapeutics Market

  • 3.1. Protein Therapeutics Market vs Pharmaceutical Market
  • 3.2. Current and Future Market Analysis to 2020
    • 3.2.1. Market Segmentation
    • 3.2.2. Market Dynamics
      • 3.2.2.1. Drivers
        • 3.2.2.1.1. Increasing Healthcare Expenditure in the Emerging Markets
        • 3.2.2.1.2. Government Initiatives to Improve the Healthcare Services
        • 3.2.2.1.3. Rising Prevalence of Chronic Diseases
        • 3.2.2.1.4. Growing Geriatric Population
      • 3.2.2.2. Challenges
        • 3.2.2.2.1. High Cost of Production and Treatment
        • 3.2.2.2.2. Competition from Biosimilars
        • 3.2.2.2.3. Patent Expiry of Blockbuster Drugs
      • 3.2.2.3. Opportunities
        • 3.2.2.3.1. Potential for Bispecific Monoclonal Antibodies
        • 3.2.2.3.2. Unmet Medical Needs in the Developing Countries

4. Industry Performance

  • 4.1. Monoclonal Antibodies (mAbs)
    • 4.1.1. Scientific Insight
    • 4.1.2. Current and Future Market Analysis to 2020
    • 4.1.3. By Application
    • 4.1.4. Key Geographical Markets
    • 4.1.5. Key Players and Drugs
    • 4.1.6. Recent Developments
  • 4.2. Erythropoietin (EPO)
    • 4.2.1. Scientific Insight
    • 4.2.2. Current and Future Market Analysis to 2020
    • 4.2.3. By Application
    • 4.2.4. Key Geographical Markets
    • 4.2.5. Key Players and Drugs
    • 4.2.6. Recent Developments
  • 4.3. Insulin
    • 4.3.1. Scientific Insight
    • 4.3.2. Current and Future Market Analysis to 2020
    • 4.3.3. By Application
    • 4.3.4. Key Geographical Markets
    • 4.3.5. Key Players and Drugs
    • 4.3.6. Recent Developments
  • 4.4. Interferon (IFN)
    • 4.4.1. Scientific Insight
    • 4.4.2. Current and Future Market Analysis to 2020
    • 4.4.3. By Application
    • 4.4.4. Key Geographical Markets
    • 4.4.5. Key Players and Drugs
    • 4.4.6. Recent Developments
  • 4.5. Human Growth Hormone (HGH)
    • 4.5.1. Scientific Insight
    • 4.5.2. Current and Future Market Analysis to 2020
    • 4.5.3. Key Geographical Markets
    • 4.5.4. Key Players and Drugs
    • 4.5.5. Recent Developments
  • 4.6. Blood Clotting Factor
    • 4.6.1. Scientific Insight
    • 4.6.2. Current and Future Market Analysis to 2020
    • 4.6.3. By Factor Type
    • 4.6.4. Key Geographical Markets
    • 4.6.5. Key Players and Drugs
    • 4.6.6. Recent Developments
  • 4.7. Follicle Stimulating Hormone (FSH)
    • 4.7.1. Scientific Insight
    • 4.7.2. Current and Future Market Analysis to 2020
    • 4.7.3. Key Players and Drugs
    • 4.7.4. Recent Developments
  • 4.8. Granulocyte Colony Stimulating Factor (G-CSF)
    • 4.8.1. Scientific Insight
    • 4.8.2. Current and Future Market Analysis to 2020
    • 4.8.3. Key Geographical Markets
    • 4.8.4. Key Players and Drugs
    • 4.8.5. Recent Developments

5. Advanced Phase Drugs Analysis

6. Emerging Market Trends

  • 6.1. Gaining Momentum: Strategic Activities among Players to Develop Novel Treatments
  • 6.2. Effective Delivery Methods: Improving the Reach of Therapies
  • 6.3. Players Investing Heavily in Multiple Sclerosis and Cancer Therapeutics
  • 6.4. Increasing Focus on Development of Biobetters

7. Porters Five Forces Analysis

8. Key Players

  • 8.1. Johnson & Johnson
  • 8.2. Biogen Idec Inc.
  • 8.3. Eli Lilly & Company
  • 8.4. Sanofi-Aventis
  • 8.5. Merck Serono S.A.
  • 8.6. Roche Group
  • 8.7. Amgen Inc.
  • 8.8. Pfizer
  • 8.9. Abbott Laboratories
  • 8.10. Novo Nordisk

List of Figures:

  • Figure 3-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2014
  • Figure 3-2: Global - Protein Therapeutics Market (Billion US$), 2013-2020
  • Figure 3-3: Global - Protein Therapeutics Market by Segment (%), 2014
  • Figure 3-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2020
  • Figure 4-1: Global - Monoclonal Antibodies Market (Billion US$), 2013-2020
  • Figure 4-2: Global - Monoclonal Antibodies Market by Application (%), 2014
  • Figure 4-3: Global - Monoclonal Antibodies Application in Cancer Treatment (Billion US$), 2013-2020
  • Figure 4-4: Global - Monoclonal Antibodies Application in Rheumatoid Arthritis Treatment (Billion US$), 2013-2020
  • Figure 4-5: Global - Monoclonal Antibodies Application in Other Chronic Diseases Treatment (Billion US$), 2013-2020
  • Figure 4-6: US - Monoclonal Antibodies Market (Billion US$), 2013-2020
  • Figure 4-7: Europe - Monoclonal Antibodies Market (Billion US$), 2013-2020
  • Figure 4-8: Japan - Monoclonal Antibodies Market (Billion US$), 2013-2020
  • Figure 4-9: Global - Monoclonal Antibody Market by Key Players (%) (2014)
  • Figure 4-10: Global - Erythropoietin Market (Billion US$), 2012-2018
  • Figure 4-11: Global - Erythropoietin Market by Segment (%) (2014)
  • Figure 4-12: Global - Number of Patients on Dialysis (Million), 2014 & 2020
  • Figure 4-13: Global - Breakup of Patients on Dialysis by Region (%), 2014
  • Figure 4-14: Global - Number of New Cancer Cases (Million), 2012 & 2020
  • Figure 4-15: Global - Breakup of New Cancer Cases by Region (%), 2020
  • Figure 4-16: US - Erythropoietin Market (Billion US$), 2013-2020
  • Figure 4-17: Europe - Erythropoietin Market (Billion US$), 2013-2020
  • Figure 4-18: Global - Erythropoietin Market by Key Player (%), (2014)
  • Figure 4-19: Global - Insulin Market (Billion US$), 2013-2020
  • Figure 4-20: Global - Number of Diabetic Patients (Million), 2013 & 2035
  • Figure 4-21: US - Insulin Market (Billion US$), 2013-2020
  • Figure 4-22: Europe - Insulin Market (Billion US$), 2013-2020
  • Figure 4-23: Asia - Insulin Market (Billion US$), 2013-2020
  • Figure 4-24: Global - Insulin Market by Key Players (%) (2014)
  • Figure 4-25: Global - Insulin Market by Products (%)(2014)
  • Figure 4-26: Global - Interferon Market (Billion US$), 2013-2020
  • Figure 4-27: Global - Interferon Market by Segment (%) (2014)
  • Figure 4-28: Global - Interferon Alpha Market (Billion US$), 2012-2014
  • Figure 4-29: Global - Interferon Beta Market (Billion US$), 2012-2014
  • Figure 4-30: US - Interferon Market (Billion US$), 2013-2020
  • Figure 4-31: Europe - Interferon Market (Billion US$), 2013-2020
  • Figure 4-32: Global - Interferon Market by Key Player (%) (2014)
  • Figure 4-33: Global - Human Growth Hormone Market (Billion US$), 2013-2020
  • Figure 4-34: US - Human Growth Hormone Market (Billion US$), 2013-2020
  • Figure 4-35: Europe - Human Growth Hormone Market (Billion US$), 2013-2020
  • Figure 4-36: Global - Human Growth Hormone Market by Key Players (%) (2014)
  • Figure 4-37: Global - Blood Clotting Factor Market (Billion US$), 2013-2020
  • Figure 4-38: Global - Blood Clotting Factor Market by Segment (%) (2014)
  • Figure 4-39: Global - Blood Clotting Recombinant Factor VIII Market (Billion US$), 2013-2020
  • Figure 4-40: Global - Recombinant Blood Clotting Factor VII Market (Billion US$), 2013-2020
  • Figure 4-41: Global - Recombinant Blood Clotting Factor Market IX (Billion US$), 2013-2020
  • Figure 4-42: US - Blood Clotting Factor Market (Billion US$), 2013-2020
  • Figure 4-43: Europe - Blood Clotting Factor Market (Billion US$), 2013-2020
  • Figure 4-44: Global - Blood Clotting Factor Market by Key Players (%) (2014)
  • Figure 4-45: Global - Follicle Stimulating Hormone Market (Billion US$), 2013-2020
  • Figure 4-46: Global - Granulocyte Colony Stimulating Factor Market (Billion US$), 2013-2020
  • Figure 4-47: US - Granulocyte Colony-Stimulating Factor Market (Billion US$), 2013-2020
  • Figure 4-48: Europe - Granulocyte Colony-Stimulating Factor Market (Billion US$), 2013-2020
  • Figure 7-1: Porters Five Forces Analysis

List of Tables:

  • Table 3-1: US & Europe - Major Drugs Patent Expiry in Protein Therapeutics Market
  • Table 4-1: Global - Key Players and Drugs in Monoclonal Antibody Market (Billion US$), 2012-2014
  • Table 4-2: Global - Key Players and Drugs in Erythropoietin Alfa Market (Billion US$), 2012-2014
  • Table 4-3: Global - Key Players and Drugs in Erythropoietin Beta Market (Billion US$), 2012-2014
  • Table 4-4: Global - Key Players and Drugs in Darbepoetin Market (Billion US$), 2012-2014
  • Table 4-5: US - Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2035f
  • Table 4-6: Europe - Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2035
  • Table 4-7: China - Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2035f
  • Table 4-8: Global - Key Players and Drugs in Interferon Alpha Market (Billion US$), 2012-2014
  • Table 4-9: Global - Key Players and Drugs in Interferon Beta Market (Billion US$), 2012-2014
  • Table 4-10: Global - Key Players and Drugs in Human Growth Hormone Market (Billion US$), 2012-2014
  • Table 4-11: Global - Key Players and Drugs in Blood Clotting Factor Market (Billion US$), 2012-2014
  • Table 4-12: Global - Key Players and Drugs in Follicle Stimulating Hormone Market (Billion US$), 2012-2014
  • Table 4-13: Global - Key Players and Drugs in Granulocyte Colony Stimulating Factor Market (Billion US$), 2012-2014
  • Table 5-1: Advanced Phase Protein Therapeutics
  • Table 8-1: Johnson & Johnson - Key Products in Protein Therapeutics
  • Table 8-2: Biogen - Key Products in Protein Therapeutics
  • Table 8-3: Eli Lilly - Key Products in Protein Therapeutics
  • Table 8-4: Sanofi-Aventis - Key Products in Protein Therapeutics
  • Table 8-5: Merck Serono - Key Products in Protein Therapeutics
  • Table 8-6: Roche - Key Products in Protein Therapeutics
  • Table 8-7: Amgen Inc. - Key Products in Protein Therapeutics
  • Table 8-8: Pfizer Inc. - Key Products in Protein Therapeutics
  • Table 8-9: Abbott Laboratories - Key Products in Protein Therapeutics
  • Table 8-10: Novo Nordisk - Key Products in Protein Therapeutics
Back to Top